Related Experiment Video
Updated: Oct 16, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Exogenous mutant p53 DNA enhanced cisplatin-induced apoptosis in TSGH-8301 human bladder cancer cells
1Department of Biochemistry, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China.
Background:
The influence of tumor suppressor gene p53 on the apoptosis of bladder cancer cells is not completely understood. In this study, the requirement for p53 in the cisplatin-induced apoptosis of human bladder cancer cells TSGH-8301 was investigated.
Materials And Methods:
TSGH-8301 cells, which contain endogenous wild type p53 genes, were transfected with expression vectors containing p53 cDNA mutated at codon 173. Stable mutant p53 transfectant clones were confirmed by Southern blotting and Western blotting. The cellular response to cisplatin was determined on the basis of (a) cells viability, (b) apoptotic DNA fragmentation, and (c) nuclear condensation.
Results:
Cells containing an exogenous mutant p53 sequence had increased sensitivity to cisplatin by undergoing apoptosis compared with parental TSGH8301 cells. In contrast, no difference was observed in those clones with rearranged or undetectable exogenous mutant p53 cDNA. However, analysis of p53 mRNA with RT-PCR sequencing indicated that none of the transfectant clones expressed exogenous mutant p53 mRNA.
Conclusion:
The transfectants had lost the expression of mutant p53 during selection; however, they could still enhance the expression of wild-type p53, which conferred sensitivity to cisplatin.
Implication:
Transient expression of mutant p53 protein in TSGH8301 cells may induce an irreversibly stabilization of p53 and increase the steady state of p53 expression.
Insights
The tumor suppressor gene p53 enhances cisplatin-induced apoptosis in bladder cancer cells. Even without mutant p53 expression, wild-type p53 stabilization increases cancer cell sensitivity to chemotherapy.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The role of tumor suppressor gene p53 in bladder cancer cell apoptosis remains unclear.
- Investigating the necessity of p53 for cisplatin-induced apoptosis in human bladder cancer cell line TSGH-8301.
Purpose of the Study:
- To determine the role of wild-type p53 in mediating apoptosis.
- To understand the effect of mutant p53 expression on bladder cancer cell sensitivity to cisplatin.
Main Methods:
- TSGH-8301 cells with wild-type p53 were transfected with mutated p53 cDNA.
- Stable transfectants were confirmed using Southern and Western blotting.
- Cellular response to cisplatin was assessed via viability, DNA fragmentation, and nuclear condensation assays.
Main Results:
- Cells with exogenous mutant p53 showed increased cisplatin sensitivity and apoptosis.
- No significant difference in sensitivity was observed in clones with rearranged or undetectable mutant p53.
- RT-PCR sequencing revealed no exogenous mutant p53 mRNA expression in transfectants.
Conclusions:
- Transfectants lost mutant p53 expression but enhanced wild-type p53 expression, conferring cisplatin sensitivity.
- Transient mutant p53 expression may lead to irreversible p53 stabilization and increased steady-state p53 levels.
More Related Videos
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
04:20Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity
Published on: February 9, 2024
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Intrinsic Apoptotic Pathway